The World's Greatest Investing Community
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
**Physicians love Epocrates' mobile applications, because they reduce prescription errors, improve patient care, and save time.
**Epocrates is disrupting the face-to-face sales model used by pharma companies by offering a more targeted and cost-effective way to introduce physicians to new and existing drugs.
**The company has ridden its first-mover advantage to an 80% market share that reaches 45% of all U.S. physicians, and it benefits from a recurring revenue base to fund R&D for new products.
Epocrates announced the appointment of Matthew Kaminer as general counsel and secretary of Epocrates, effective June 27, 2011. Mr. Kaminer succeeds Paul Banta, who has resigned as executive vice president, general counsel and secretary, effective July 1, 2011 to pursue other interests.
What is the reason for the management change? Does the change affect the Stock Advisor recommendation?
PshawFool